imipramine has been researched along with Recrudescence in 148 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Excerpt | Relevance | Reference |
|---|---|---|
| "It has been suggested that maintenance treatment of patients who have remitted panic disorder with agoraphobia beyond the six months of acute phase imipramine treatment may decrease the risk of relapse." | 9.10 | Duration of imipramine therapy and relapse in panic disorder with agoraphobia. ( Mavissakalian, MR; Perel, JM, 2002) |
| "The results from our 1 year placebo-controlled maintenance/discontinuation study in remitted panic disorder with agoraphobia patients confirmed the significant prophylactic effectiveness of imipramine maintenance treatment but suggested that this may be necessary in only 37% of the patients who relapse following discontinuation of 6 months acute imipramine treatment." | 9.09 | 2nd year maintenance and discontinuation of imipramine in panic disorder with agoraphobia. ( Mavissakalian, MR; Perel, JM, 2001) |
| "Several issues remain to be ascertained beyond the acute response to imipramine hydrochloride in patients with panic disorder." | 9.07 | Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia. ( Mavissakalian, M; Perel, JM, 1992) |
| "This study was designed to assess and compare the differential relapse rates of patients with panic disorder and agoraphobia after discontinuation of acute treatment (6 months) or acute plus maintenance treatment (18 months) with imipramine." | 9.07 | Protective effects of imipramine maintenance treatment in panic disorder with agoraphobia. ( Mavissakalian, M; Perel, JM, 1992) |
| "Imipramine was gradually withdrawn after 6 months." | 6.67 | A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. ( Anastasiades, P; Clark, DM; Gelder, M; Hackmann, A; Middleton, H; Salkovskis, PM, 1994) |
| "Of 60 depressed alcoholics who completed an open trial of imipramine, 27 (45%) responded with improvement in both mood and drinking behavior, and eight (13%) responded after further dosage increases or treatment with disulfiram." | 6.67 | Imipramine treatment of alcoholism with comorbid depression. ( Harrison, W; McGrath, PJ; Nunes, EV; Ocepek-Welikson, K; Quitkin, FM; Stewart, JP; Tricamo, E, 1993) |
| "The additive pharmacologic effects of imipramine with pseudoephedrine for the treatment of monosymptomatic nocturnal enuresis in children were well tolerated, and gave significantly faster results than single drug therapy using imipramine." | 5.15 | Comparison between imipramine and imipramine combined with pseudoephedrine in 5-12-year-old children with uncomplicated enuresis: a double-blind clinical trial. ( Abedin Zadeh, M; Kholaseh Zadeh, G; Moslemi, MK, 2011) |
| "It has been suggested that maintenance treatment of patients who have remitted panic disorder with agoraphobia beyond the six months of acute phase imipramine treatment may decrease the risk of relapse." | 5.10 | Duration of imipramine therapy and relapse in panic disorder with agoraphobia. ( Mavissakalian, MR; Perel, JM, 2002) |
| "The results from our 1 year placebo-controlled maintenance/discontinuation study in remitted panic disorder with agoraphobia patients confirmed the significant prophylactic effectiveness of imipramine maintenance treatment but suggested that this may be necessary in only 37% of the patients who relapse following discontinuation of 6 months acute imipramine treatment." | 5.09 | 2nd year maintenance and discontinuation of imipramine in panic disorder with agoraphobia. ( Mavissakalian, MR; Perel, JM, 2001) |
| "After 12 weeks of acute phase treatment in a double-blind, randomized, parallel-group, multi-center trial of sertraline or imipramine, patients with chronic depression (> or = 2 years in major depression, or major depression superimposed on dysthymia) continued study drug for 16 weeks." | 5.09 | Sertraline versus imipramine to prevent relapse in chronic depression. ( DeBattista, C; Friedman, RA; Gelenberg, AJ; Hirschfeld, RM; Howland, RH; Keller, MB; Klein, D; Kocsis, JH; Koran, LM; Kornstein, SG; LaVange, LM; Rush, AJ; Schatzberg, AF; Thase, ME, 2001) |
| "This paper presents a cost-utility analysis of three maintenance treatments for recurrent depression: interpersonal therapy (IPT-M), imipramine drug therapy (Drug), and a combination of the two." | 5.08 | Cost utility analysis of maintenance treatment for recurrent depression. ( Frank, E; Greenhouse, J; Kamlet, MS; Kupfer, D; Paul, N; Wade, M, 1995) |
| "Nefazodone is a well-tolerated and effective antidepressant for the treatment of major depressive disorder." | 5.07 | A double-blind comparison of nefazodone, imipramine, and placebo in major depression. ( Ecker, JA; Elie, R; Faludi, G; Fontaine, R; Kaplita, S; Kensler, TT; Ontiveros, A; Roberts, DL, 1994) |
| " The present study provided systematic data from a double blind comparison of maintenance therapy (up to 8 months) of panic disorder with or without agoraphobia with alprazolam, imipramine, or placebo in 181 patients who had responded to the same regimen in a randomized 8-week treatment trial." | 5.07 | Maintenance drug therapy of panic disorder. ( Ayuso, JL; Cassano, GB; Curtis, GC; Massana, J; Perugi, G; Udina, C, 1993) |
| "Forty-eight patients with panic disorder completing 8 months of maintenance treatment with alprazolam (mean dose, 5." | 5.07 | Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper. ( Rickels, K; Schweizer, E; Weiss, S; Zavodnick, S, 1993) |
| "Several issues remain to be ascertained beyond the acute response to imipramine hydrochloride in patients with panic disorder." | 5.07 | Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia. ( Mavissakalian, M; Perel, JM, 1992) |
| "This study was designed to assess and compare the differential relapse rates of patients with panic disorder and agoraphobia after discontinuation of acute treatment (6 months) or acute plus maintenance treatment (18 months) with imipramine." | 5.07 | Protective effects of imipramine maintenance treatment in panic disorder with agoraphobia. ( Mavissakalian, M; Perel, JM, 1992) |
| "In the early 1980s, the National Institute of Mental Health supported a multicenter, randomized, controlled, clinical trial on unipolar and bipolar disorder to evaluate the comparative efficacies of lithium carbonate, imipramine hydrochloride, a lithium-imipramine combination, and placebo in preventing the recurrence of affective disorders." | 5.07 | Methodologic issues in maintenance therapy clinical trials. ( Greenhouse, JB; Kupfer, DJ; Prien, RF; Stangl, D, 1991) |
| " In the continuation and taper phases combined there were 211 adverse events in the paroxetine group, 147 on imipramine and 100 on placebo." | 2.82 | Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression. ( Abi-Jaoude, E; Healy, D; Jureidini, J; Le Noury, J; Nardo, JM; Raven, M; Tufanaru, C, 2016) |
| "Imipramine caused an increase in the GH ratio in all subgroups." | 2.68 | Growth hormone secretion timing in depression: clinical outcome comparisons. ( Franz, B; Grochocinski, VJ; Jarrett, DB; Kupfer, DJ; Miewald, JM, 1995) |
| "The psychometric analysis of the Melancholia Scale in the continuation or post-ECT phase showed that relapsing patients displayed a pattern with lack of interests, impaired concentration, depressed mood and anxiety among the less severe symptoms (first-compartment symptoms)." | 2.68 | Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. ( Bech, P; Black, C; Clemmesen, L; Lauritzen, L; Lunde, M; Odgaard, K; Ohrström, J, 1996) |
| "Differences in recurrence rates after the switch to placebo from phenelzine and imipramine could be due to the two drugs' different mechanisms of action or to baseline differences in the two populations." | 2.68 | Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission. ( McGrath, PJ; Quitkin, FM; Stewart, JW; Tricamo, E, 1997) |
| "Imipramine was gradually withdrawn after 6 months." | 2.67 | A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. ( Anastasiades, P; Clark, DM; Gelder, M; Hackmann, A; Middleton, H; Salkovskis, PM, 1994) |
| "Of 60 depressed alcoholics who completed an open trial of imipramine, 27 (45%) responded with improvement in both mood and drinking behavior, and eight (13%) responded after further dosage increases or treatment with disulfiram." | 2.67 | Imipramine treatment of alcoholism with comorbid depression. ( Harrison, W; McGrath, PJ; Nunes, EV; Ocepek-Welikson, K; Quitkin, FM; Stewart, JP; Tricamo, E, 1993) |
| " The question was whether maintaining antidepressant medication at the dosage used to treat the acute episode beyond 3 years would continue to provide a significant prophylactic effect compared with medication discontinuation after the 3 years of effective maintenance treatment." | 2.67 | Five-year outcome for maintenance therapies in recurrent depression. ( Cornes, C; Frank, E; Grochocinski, VJ; Kupfer, DJ; Mallinger, AG; McEachran, AB; Perel, JM; Thase, ME, 1992) |
| "Patients who failed to respond to sustained, adequate treatment with the tricyclic imipramine (mean maximum dosage = 260 mg/day) and interpersonal psychotherapy were withdrawn from imipramine and treated in a standardized, but open-label 6-week trial with either phenelzine (N = 4; 60 mg/day) or tranylcypromine (N = 36; mean = 38." | 2.67 | Treatment of imipramine-resistant recurrent depression, III: Efficacy of monoamine oxidase inhibitors. ( Frank, E; Hamer, T; Kupfer, DJ; Mallinger, AG; Thase, ME, 1992) |
| " A second question was whether maintaining antidepressant medication at the dosage used to treat the acute episode rather than decreasing to a "maintenance" dosage would provide prophylaxis superior to that observed in earlier trials in which a maintenance dosage strategy was employed." | 2.67 | Three-year outcomes for maintenance therapies in recurrent depression. ( Cornes, C; Frank, E; Grochocinski, VJ; Jarrett, DB; Kupfer, DJ; Mallinger, AG; McEachran, AB; Perel, JM; Thase, ME, 1990) |
| " The authors report on the lack of efficacy of adjunctive L-triiodothyronine (T3; 25 micrograms/day) in a sample of 20 outpatient unipolar depressives who had not responded to greater than or equal to 12 weeks of treatment with imipramine (mean dosage = 240 mg/day) and interpersonal psychotherapy." | 2.66 | Treatment of imipramine-resistant recurrent depression: I. An open clinical trial of adjunctive L-triiodothyronine. ( Jarrett, DB; Kupfer, DJ; Thase, ME, 1989) |
| "Endogenous anxiety (anxiety hysteria, agoraphobia with panic attacks) is characterized by sudden, spontaneous panic attacks accompanied by multiple autonomic symptoms, overwhelming fear, a flight response, and polyphobic behavior." | 2.65 | Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. ( Ballenger, J; Jacobsen, G; Sheehan, DV, 1980) |
| "Lithium carbonate was found to help prevent depressive relapse among patients with unipolar disease, and relapse of any type among those with bipolar II disease." | 2.65 | Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison. ( Howard, A; Kane, JM; Nayak, DD; Quitkin, FM; Ramos-Lorenzi, JR; Rifkin, A, 1982) |
| "The lithium carbonate-treated group had fewer manic episodes than the other groups." | 2.65 | Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. ( Johnson, WE; Kupfer, DJ; Mansky, PA; Prien, RF; Small, JG; Tuason, VB; Voss, CB, 1984) |
| "In a controlled outcome study of phobias, 111 adult patients (69% women, 31% men) received a course of 26 weekly treatment sessions consisting of (1) behavior therapy and imipramine hydrochloride (2) behavior therapy and placebo, or (3) supportive psychotherapy and imipramine." | 2.64 | Behavior therapy, supportive psychotherapy, imipramine, and phobias. ( Klein, DF; Woerner, MG; Zitrin, CM, 1978) |
| "Nocturnal enuresis is a common problem occurring in 15% of children at 5 years of age." | 2.39 | Diagnosis and management of nocturnal enuresis. ( Gandhi, KK, 1994) |
| "We present a case of a dilated cardiomyopathy, which seemed idiopathic, but occurred during treatment with imipramine and recovered after its withdrawal." | 1.33 | Recurrence of dilated cardiomyopathy after re-introduction of a tricyclic antidepressant. ( Bouhour, JB; Briec, F; Delaire, C; Trochu, JN, 2006) |
| "Nocturnal enuresis is a common childhood disorder." | 1.31 | Combined pharmacotherapy for nocturnal enuresis. ( Fujinaga, S; Kaneko, K; Ohtomo, Y; Shimizu, T; Yamashiro, Y, 2001) |
| "Major depressive disorder is often marked by repeated episodes of depression." | 1.30 | Recovery from major depression. A 10-year prospective follow-up across multiple episodes. ( Coryell, W; Endicott, J; Keller, MB; Leon, AC; Maser, JD; Mueller, TI; Shea, MT; Solomon, DA; Warshaw, M, 1997) |
| "Imipramine doses were individually adjusted until doses yielded plasma concentrations of imipramine plus desipramine that were well above 400 nmol/L or until all neuropathy symptoms had vanished." | 1.28 | Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms. ( Beck-Nielsen, H; Frøland, A; Gram, LF; Sindrup, SH; Skjold, T, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 57 (38.51) | 18.7374 |
| 1990's | 67 (45.27) | 18.2507 |
| 2000's | 17 (11.49) | 29.6817 |
| 2010's | 7 (4.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldwin, DS | 1 |
| Green, M | 1 |
| Montgomery, SA | 3 |
| Gressier, F | 1 |
| Rotenberg, S | 1 |
| Ait Tayeb, AEK | 1 |
| Colle, R | 1 |
| Hardy, P | 1 |
| Becquemont, L | 1 |
| Verstuyft, C | 1 |
| Corruble, E | 1 |
| Le Noury, J | 1 |
| Nardo, JM | 1 |
| Healy, D | 1 |
| Jureidini, J | 1 |
| Raven, M | 1 |
| Tufanaru, C | 1 |
| Abi-Jaoude, E | 1 |
| Alves, ND | 1 |
| Correia, JS | 1 |
| Patrício, P | 1 |
| Mateus-Pinheiro, A | 1 |
| Machado-Santos, AR | 1 |
| Loureiro-Campos, E | 1 |
| Morais, M | 1 |
| Bessa, JM | 1 |
| Sousa, N | 1 |
| Pinto, L | 1 |
| Tuncel, A | 1 |
| Mavituna, I | 1 |
| Nalcacioglu, V | 1 |
| Tekdogan, U | 1 |
| Uzun, B | 1 |
| Atan, A | 1 |
| Powell, VB | 1 |
| Abreu, N | 1 |
| Oliveira, IR | 1 |
| Sudak, D | 1 |
| Abedin Zadeh, M | 1 |
| Moslemi, MK | 1 |
| Kholaseh Zadeh, G | 1 |
| Roberson-Nay, R | 1 |
| Latendresse, SJ | 1 |
| Kendler, KS | 1 |
| Nardi, M | 1 |
| Anwander, M | 1 |
| Rüegger-Frey, B | 1 |
| Bopp-Kistler, I | 1 |
| Cardoner, N | 1 |
| Pujol, J | 1 |
| Vallejo, J | 1 |
| Urretavizcaya, M | 1 |
| Deus, J | 1 |
| López-Sala, A | 1 |
| Benlloch, L | 1 |
| Menchón, JM | 1 |
| LECOMTE, G | 1 |
| ALCALAY, R | 1 |
| Andersch, S | 1 |
| Hetta, J | 1 |
| Uhlenhuth, EH | 1 |
| Leon, AC | 3 |
| Matuzas, W | 1 |
| Monroe, SM | 4 |
| Torres, LD | 1 |
| Guillaumot, J | 1 |
| Harkness, KL | 1 |
| Roberts, JE | 3 |
| Frank, E | 30 |
| Kupfer, D | 2 |
| Briec, F | 1 |
| Delaire, C | 1 |
| Bouhour, JB | 1 |
| Trochu, JN | 1 |
| Ros, LT | 1 |
| Mathew, KK | 1 |
| Nishikawa, T | 1 |
| Tsuda, A | 1 |
| Tanaka, M | 1 |
| Koga, I | 1 |
| Uchida, Y | 1 |
| Pohl, R | 1 |
| Rainey, JM | 1 |
| Gershon, S | 1 |
| Prien, RF | 9 |
| Shopsin, B | 1 |
| Kupfer, DJ | 35 |
| Mansky, PA | 1 |
| Small, JG | 1 |
| Tuason, VB | 2 |
| Voss, CB | 1 |
| Johnson, WE | 1 |
| Jarrett, DB | 5 |
| Grochocinski, VJ | 12 |
| Thase, ME | 9 |
| Hersen, M | 1 |
| Bellack, AS | 1 |
| Himmelhoch, JM | 2 |
| Kornblith, SJ | 1 |
| Greenwald, DP | 1 |
| Quitkin, FM | 7 |
| Kane, J | 2 |
| Rifkin, A | 4 |
| Ramos-Lorenzi, JR | 2 |
| Nayak, DV | 1 |
| Kane, JM | 1 |
| Nayak, DD | 1 |
| Howard, A | 1 |
| Brown, WA | 1 |
| Qualls, CB | 1 |
| Ghoneim, MA | 1 |
| Shehab-El-Din, AB | 1 |
| Ashamallah, AK | 1 |
| Gaballah, MA | 1 |
| Eilenberg, MD | 1 |
| Sheehan, DV | 1 |
| Ballenger, J | 1 |
| Jacobsen, G | 1 |
| Peet, M | 1 |
| Coppen, A | 1 |
| Mindham, RH | 3 |
| Pascalis, JG | 1 |
| Chauvot, B | 1 |
| Delisle, JP | 1 |
| Kamlet, MS | 1 |
| Paul, N | 1 |
| Greenhouse, J | 1 |
| Wade, M | 1 |
| Hirschfeld, RM | 2 |
| O'Brien, JT | 1 |
| Siris, SG | 2 |
| Bermanzohn, PC | 1 |
| Mason, SE | 1 |
| Shuwall, MA | 1 |
| Karp, JF | 1 |
| Ritenour, A | 1 |
| McEachran, A | 1 |
| Clark, DM | 1 |
| Salkovskis, PM | 1 |
| Hackmann, A | 1 |
| Middleton, H | 1 |
| Anastasiades, P | 1 |
| Gelder, M | 1 |
| Alpert, JE | 1 |
| Maddocks, A | 1 |
| Rosenbaum, JF | 3 |
| Fava, M | 1 |
| Hamvas, A | 1 |
| Nagy, F | 1 |
| Tankó, A | 1 |
| Gandhi, KK | 1 |
| Ehlers, CL | 2 |
| McEachran, AB | 10 |
| Buhari, A | 2 |
| Fontaine, R | 1 |
| Ontiveros, A | 1 |
| Elie, R | 1 |
| Kensler, TT | 1 |
| Roberts, DL | 1 |
| Kaplita, S | 1 |
| Ecker, JA | 1 |
| Faludi, G | 1 |
| Curtis, GC | 1 |
| Massana, J | 1 |
| Udina, C | 1 |
| Ayuso, JL | 1 |
| Cassano, GB | 1 |
| Perugi, G | 1 |
| Barnes, GJ | 1 |
| Jones, Q | 1 |
| Rickels, K | 1 |
| Schweizer, E | 2 |
| Weiss, S | 1 |
| Zavodnick, S | 1 |
| Perel, JM | 10 |
| Cornes, C | 4 |
| Mallinger, AG | 5 |
| Nunes, EV | 1 |
| McGrath, PJ | 2 |
| Stewart, JP | 1 |
| Harrison, W | 1 |
| Tricamo, E | 2 |
| Ocepek-Welikson, K | 1 |
| Stangl, DK | 1 |
| Franz, B | 1 |
| Miewald, JM | 2 |
| Marcus, RN | 1 |
| Mendels, J | 1 |
| Spanier, C | 1 |
| Brown, RE | 1 |
| Clark, M | 1 |
| Reynolds, CF | 2 |
| Mazumdar, S | 1 |
| Houck, PR | 3 |
| Greenhouse, JB | 3 |
| Silliman, NP | 1 |
| Lauritzen, L | 1 |
| Odgaard, K | 1 |
| Clemmesen, L | 1 |
| Lunde, M | 1 |
| Ohrström, J | 1 |
| Black, C | 1 |
| Bech, P | 1 |
| Pollack, MH | 2 |
| Pollock, RA | 1 |
| Stewart, JW | 2 |
| Agosti, V | 2 |
| Gruzman, AV | 1 |
| Solomon, DA | 2 |
| Keller, MB | 3 |
| Mueller, TI | 2 |
| Shea, MT | 2 |
| Warshaw, M | 2 |
| Maser, JD | 2 |
| Coryell, W | 2 |
| Endicott, J | 2 |
| Dew, MA | 1 |
| Hall, M | 1 |
| Buysse, DJ | 2 |
| Flint, A | 1 |
| Hyams, JS | 1 |
| Hyman, PE | 1 |
| Zuroff, DC | 1 |
| Blatt, SJ | 1 |
| Sanislow, CA | 1 |
| Bondi, CM | 1 |
| Pilkonis, PA | 3 |
| Bentkover, JD | 1 |
| Feighner, JP | 1 |
| Lipsitz, JD | 1 |
| Mannuzza, S | 1 |
| Klein, DF | 3 |
| Ross, DC | 1 |
| Fyer, AJ | 1 |
| Spanier, CA | 1 |
| Cherry, CR | 1 |
| Stapf, DM | 1 |
| Marsland, TW | 1 |
| Newton, W | 1 |
| McQuaid, JR | 1 |
| Koran, LM | 1 |
| Gelenberg, AJ | 1 |
| Kornstein, SG | 1 |
| Howland, RH | 1 |
| Friedman, RA | 1 |
| DeBattista, C | 1 |
| Klein, D | 1 |
| Kocsis, JH | 1 |
| Schatzberg, AF | 1 |
| Rush, AJ | 1 |
| LaVange, LM | 1 |
| Kaneko, K | 1 |
| Fujinaga, S | 1 |
| Ohtomo, Y | 1 |
| Shimizu, T | 1 |
| Yamashiro, Y | 1 |
| Mavissakalian, MR | 2 |
| Prasko, J | 1 |
| Horacek, J | 1 |
| Klaschka, J | 1 |
| Kosova, J | 1 |
| Ondrackova, I | 1 |
| Sipek, J | 1 |
| Zitrin, CM | 1 |
| Woerner, MG | 1 |
| Perry, P | 1 |
| Tsuang, MT | 1 |
| Doleys, DM | 1 |
| Greenblatt, M | 1 |
| Quitkin, F | 1 |
| Bennett, AE | 1 |
| Caffey, EM | 3 |
| Zelechowska, K | 1 |
| Frokiewicz, M | 1 |
| Ashcroft, GW | 1 |
| Nandi, DN | 1 |
| Ajmany, S | 1 |
| Ganguli, H | 1 |
| Banerjee, G | 1 |
| Boral, GC | 1 |
| Ghosh, A | 1 |
| Sarkar, S | 1 |
| McCann, UD | 1 |
| Ricaurte, GA | 1 |
| Elkin, I | 1 |
| Imber, SD | 1 |
| Sotsky, SM | 1 |
| Watkins, JT | 1 |
| Collins, JF | 1 |
| Beckham, E | 1 |
| Glass, DR | 1 |
| Dolan, RT | 1 |
| Evans, MD | 1 |
| Hollon, SD | 1 |
| DeRubeis, RJ | 1 |
| Piasecki, JM | 1 |
| Grove, WM | 1 |
| Garvey, MJ | 2 |
| Junker, BW | 1 |
| Hamer, T | 2 |
| Mavissakalian, M | 2 |
| Swann, AC | 1 |
| Secunda, SK | 1 |
| Stokes, PE | 1 |
| Croughan, J | 1 |
| Davis, JM | 1 |
| Koslow, SH | 1 |
| Maas, JW | 1 |
| McKnight, D | 1 |
| Wagner, EF | 1 |
| Warady, BA | 1 |
| Alon, U | 1 |
| Hellerstein, S | 1 |
| Stangl, D | 1 |
| Bulik, CM | 1 |
| Levenson, JA | 1 |
| van Marwijk, HW | 1 |
| Bekker, FM | 1 |
| Nolen, WA | 1 |
| Jansen, PA | 1 |
| van Nieuwkerk, JF | 1 |
| Hop, WC | 1 |
| Pyle, RL | 1 |
| Mitchell, JE | 1 |
| Eckert, ED | 1 |
| Hatsukami, D | 1 |
| Pomeroy, C | 1 |
| Zimmerman, R | 1 |
| Sindrup, SH | 1 |
| Gram, LF | 1 |
| Skjold, T | 1 |
| Frøland, A | 1 |
| Beck-Nielsen, H | 1 |
| Shapiro, DR | 1 |
| Fleiss, JL | 1 |
| Noyes, R | 1 |
| Cook, BL | 1 |
| Samuelson, L | 1 |
| Asarnow, JR | 1 |
| Carlson, GA | 1 |
| Strahan, A | 1 |
| Dever, A | 1 |
| Clary, C | 1 |
| Carpenter, LL | 1 |
| Sargent, M | 1 |
| Rabkin, JG | 1 |
| Cohen, BM | 1 |
| Baldessarini, RJ | 1 |
| Olig, RM | 1 |
| Staton, RD | 1 |
| Beatty, WW | 1 |
| Wilson, H | 1 |
| Biberdorf, RI | 1 |
| Hoag, SG | 1 |
| Brumback, RA | 1 |
| Howland, C | 2 |
| Shepherd, M | 2 |
| Pichot, P | 1 |
| Klett, CJ | 2 |
| Young, GC | 1 |
| Morgan, RT | 1 |
| el Islam, MF | 1 |
| Raskin, A | 1 |
| Kaplan, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia[NCT04076371] | 1,640 participants (Actual) | Interventional | 2012-01-31 | Completed | |||
| An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907 in Combination With Escitalopram in Treatment Resistant Depression[NCT00070694] | Phase 2 | 96 participants | Interventional | 2003-09-30 | Completed | ||
| Longitudinal Study of Individuals Presenting With a First Treated Episode of Depression of Mania (First Episode Project)[NCT01529905] | 200 participants (Anticipated) | Observational | 1999-06-30 | Recruiting | |||
| Evaluation of Liquid Gastric Emptying and Plasma Ghrelin in Children With Functional Dyspepsia[NCT01591174] | 30 participants (Actual) | Observational | 2012-05-31 | Completed | |||
| Virtual Mindfulness Training for Adults With History of Depression[NCT05347719] | 92 participants (Anticipated) | Interventional | 2022-09-01 | Recruiting | |||
| Characterization of the Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Peripheral Neuropathy Progression[NCT01293851] | 3 participants (Actual) | Observational | 2010-12-22 | Terminated | |||
| Increasing Access to Evidence-based Treatments for Depression: The Development and Evaluation of a Digital Training Platform for Interpersonal Psychotherapy.[NCT04619615] | 44 participants (Actual) | Interventional | 2020-07-27 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 reviews available for imipramine and Recrudescence
| Article | Year |
|---|---|
[Cognitive-behavioral therapy for depression].
Topics: Antidepressive Agents, Tricyclic; Cognitive Behavioral Therapy; Depressive Disorder; Humans; Imipram | 2008 |
Changes in the drug treatment of anxiety disorders.
Topics: Agoraphobia; Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder | 1984 |
Guidelines for the long-term treatment of depression.
Topics: Adult; Amitriptyline; Antidepressive Agents; Clinical Trials as Topic; Combined Modality Therapy; De | 1994 |
Diagnosis and management of nocturnal enuresis.
Topics: Age Factors; Behavior Therapy; Child; Circadian Rhythm; Clinical Protocols; Deamino Arginine Vasopre | 1994 |
Management of recurrent depression.
Topics: 1-Naphthylamine; Antidepressive Agents; Chronic Disease; Combined Modality Therapy; Depressive Disor | 1993 |
Efficacy in long-term treatment of depression.
Topics: Amitriptyline; Antidepressive Agents; Antidepressive Agents, Second-Generation; Depressive Disorder; | 1996 |
Clinical issues in the long-term treatment of panic disorder.
Topics: Age Factors; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Child; Cognitive B | 1996 |
Recurrent abdominal pain and the biopsychosocial model of medical practice.
Topics: Abdominal Pain; Amitriptyline; Antidepressive Agents, Tricyclic; Child; Child, Preschool; Chronic Di | 1998 |
Behavioral treatments for nocturnal enuresis in children: a review of the recent literature.
Topics: Adolescent; Behavior Therapy; Child; Child, Preschool; Conditioning, Classical; Counseling; Cues; De | 1977 |
Efficacy of ECT in affective and schizophrenic illness.
Topics: Amitriptyline; Chlorpromazine; Depression; Electroconvulsive Therapy; Evaluation Studies as Topic; H | 1977 |
Historical development of somatic therapies in affective disorders.
Topics: Affective Symptoms; Aging; Antidepressive Agents; Electroconvulsive Therapy; History, 20th Century; | 1979 |
Long-term maintenance drug therapy in recurrent affective illness: current status and issues.
Topics: Affective Symptoms; Antidepressive Agents, Tricyclic; Bipolar Disorder; Depression; Drug Evaluation; | 1977 |
Primary nocturnal enuresis: current concepts about an old problem.
Topics: Behavior Therapy; Counseling; Deamino Arginine Vasopressin; Enuresis; Female; Humans; Imipramine; Ma | 1991 |
77 trials available for imipramine and Recrudescence
| Article | Year |
|---|---|
Lack of efficacy of moclobemide or imipramine in the treatment of recurrent brief depression: results from an exploratory randomized, double-blind, placebo-controlled treatment study.
Topics: Adolescent; Adult; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; | 2014 |
Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Depressive Disorder, Major; Double-Blin | 2016 |
Comparison between imipramine and imipramine combined with pseudoephedrine in 5-12-year-old children with uncomplicated enuresis: a double-blind clinical trial.
Topics: Antidepressive Agents, Tricyclic; Child; Child, Preschool; Double-Blind Method; Drug Administration | 2011 |
A 15-year follow-up study of patients with panic disorder.
Topics: Activities of Daily Living; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Sec | 2003 |
Psychopathology of panic attacks in panic disorder.
Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Cognition; Humans; I | 2006 |
Prophylactic effect of neuroleptics in symptom-free schizophrenics.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Diazepam; Female; Haloperidol; Humans; Imipramine; Male | 1982 |
Changes in the drug treatment of anxiety disorders.
Topics: Agoraphobia; Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder | 1984 |
NIMH report. Five-center study clarifies use of lithium, imipramine for recurrent affective disorders.
Topics: Bipolar Disorder; Clinical Trials as Topic; Depressive Disorder; Drug Therapy, Combination; Humans; | 1984 |
Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination.
Topics: Actuarial Analysis; Adult; Ambulatory Care; Bipolar Disorder; Clinical Trials as Topic; Depressive D | 1984 |
Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. A double-blind study.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Bipolar Disorder; Clinical Trials as Topic; Double-Blin | 1981 |
Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison.
Topics: Adolescent; Adult; Age Factors; Aged; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Dr | 1982 |
Evolution of the rectal bladder as a method for urinary diversion.
Topics: Clinical Trials as Topic; Humans; Imipramine; Placebos; Postoperative Complications; Pyelonephritis; | 1981 |
A follow-up report and double blind comparative study of amoxapine and imipramine for the treatment of depressive inpatients.
Topics: Adult; Aged; Amoxapine; Clinical Trials as Topic; Depressive Disorder; Dibenzoxazepines; Double-Blin | 1982 |
Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.
Topics: Adult; Anxiety; Depression; Double-Blind Method; Female; Humans; Hypochondriasis; Hysteria; Imiprami | 1980 |
Continuation therapy with tricyclic antidepressants in relapsing depressive illness.
Topics: Adult; Aged; Amitriptyline; Depressive Disorder; Female; Humans; Imipramine; Male; Middle Aged; Recu | 1981 |
Cost utility analysis of maintenance treatment for recurrent depression.
Topics: Adult; Aged; Combined Modality Therapy; Cost-Benefit Analysis; Costs and Cost Analysis; Depression; | 1995 |
Maintenance imipramine therapy for secondary depression in schizophrenia. A controlled trial.
Topics: Adult; Antipsychotic Agents; Benztropine; Delayed-Action Preparations; Depressive Disorder; Double-B | 1994 |
A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder.
Topics: Adolescent; Adult; Cognitive Behavioral Therapy; Combined Modality Therapy; Desensitization, Psychol | 1994 |
Childhood psychopathology retrospectively assessed among adults with early onset major depression.
Topics: 1-Naphthylamine; Adolescent; Adult; Anxiety Disorders; Child; Child Behavior Disorders; Comorbidity; | 1994 |
Persistent effects of antidepressants: EEG sleep studies in depressed patients during maintenance treatment.
Topics: Adult; Aged; Combined Modality Therapy; Depressive Disorder; Double-Blind Method; Electroencephalogr | 1994 |
A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
Topics: Adult; Aged; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Admini | 1994 |
Maintenance drug therapy of panic disorder.
Topics: Agoraphobia; Alprazolam; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Imipramine; | 1993 |
Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper.
Topics: Adult; Alprazolam; Ambulatory Care; Dose-Response Relationship, Drug; Double-Blind Method; Drug Admi | 1993 |
Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression.
Topics: Adult; Combined Modality Therapy; Depressive Disorder; Dose-Response Relationship, Drug; Female; Hum | 1993 |
Imipramine treatment of alcoholism with comorbid depression.
Topics: Adult; Affect; Alcohol Drinking; Alcoholism; Comorbidity; Depressive Disorder; Disulfiram; Dose-Resp | 1993 |
Growth hormone secretion timing in depression: clinical outcome comparisons.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Electroencephalography; Female; Growth | 1995 |
Nefazodone in the treatment of severe, melancholic, and recurrent depression.
Topics: Adolescent; Adult; Age of Onset; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder | 1996 |
The prophylaxis of depressive episodes in recurrent depression following discontinuation of drug therapy: integrating psychological and biological factors.
Topics: Adult; Antidepressive Agents, Tricyclic; Combined Modality Therapy; Depressive Disorder; Female; Fol | 1996 |
Economic analysis of treating depression with nefazodone v. imipramine.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cost-Benefit Analysis; D | 1996 |
Treatment outcome in recurrent major depression: a post hoc comparison of elderly ("young old") and midlife patients.
Topics: Adult; Age Factors; Aged; Amitriptyline; Combined Modality Therapy; Depressive Disorder; Double-Blin | 1996 |
Applications of a mixture survival model with covariates to the analysis of a depression prevention trial.
Topics: Antidepressive Agents, Tricyclic; Depression; Female; Humans; Imipramine; Likelihood Functions; Male | 1996 |
Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tri | 1996 |
Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission.
Topics: Adult; Chronic Disease; Depressive Disorder; Drug Administration Schedule; Female; Humans; Imipramin | 1997 |
Six month follow-up of early-onset chronic depression.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; | 1996 |
[The treatment of nocturnal enuresis in children].
Topics: Adolescent; Amitriptyline; Antidepressive Agents, Tricyclic; Child; Child, Preschool; Drug Evaluatio | 1997 |
The impact of treatment resistance on depressive relapse following electroconvulsive therapy.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Combined Modality Therap | 1997 |
Vulnerability to depression: reexamining state dependence and relative stability.
Topics: Adult; Attitude; Chi-Square Distribution; Cognitive Behavioral Therapy; Depressive Disorder; Disease | 1999 |
Recurrence after recovery from major depressive disorder during 15 years of observational follow-up.
Topics: Adult; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder; Electroconvulsive Ther | 1999 |
One year clinical and psychosocial outcomes of early-onset chronic depression.
Topics: Adult; Age Factors; Antidepressive Agents, Tricyclic; Chronic Disease; Depressive Disorder; Female; | 1999 |
Specific phobia 10-16 years after treatment.
Topics: Adult; Age of Onset; Antidepressive Agents, Tricyclic; Behavior Therapy; Chi-Square Distribution; Co | 1999 |
Interpersonal psychotherapy and antidepressant medication: evaluation of a sequential treatment strategy in women with recurrent major depression.
Topics: Adult; Age of Onset; Aged; Antidepressive Agents, Tricyclic; Clinical Protocols; Cohort Studies; Com | 2000 |
Are there differences by gender in response to pharmacotherapy for depression?
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Tricyclic; Chi-Squa | 2000 |
Sertraline versus imipramine to prevent relapse in chronic depression.
Topics: Adult; Aged; Chronic Disease; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; D | 2001 |
2nd year maintenance and discontinuation of imipramine in panic disorder with agoraphobia.
Topics: Agoraphobia; Antidepressive Agents, Tricyclic; Drug Administration Schedule; Female; Humans; Imipram | 2001 |
Duration of imipramine therapy and relapse in panic disorder with agoraphobia.
Topics: Adult; Agoraphobia; Analysis of Variance; Antidepressive Agents, Tricyclic; Chi-Square Distribution; | 2002 |
Bright light therapy and/or imipramine for inpatients with recurrent non-seasonal depression.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Double-Blind Method; Female; Hu | 2002 |
Behavior therapy, supportive psychotherapy, imipramine, and phobias.
Topics: Adult; Agoraphobia; Behavior Therapy; Desensitization, Psychologic; Female; Follow-Up Studies; Human | 1978 |
The prophylactic effect of lithium and imipramine in bipolar II and unipolar patients: a preliminary report [proceedings].
Topics: Bipolar Disorder; Clinical Trials as Topic; Humans; Imipramine; Lithium; Recurrence | 1979 |
A clinical evaluation of depressives found in a rural survey in India.
Topics: Depression; Humans; Imipramine; India; Placebos; Psychological Tests; Recurrence; Rural Population; | 1976 |
Five-year outcome for maintenance therapies in recurrent depression.
Topics: Adult; Depressive Disorder; Double-Blind Method; Female; Follow-Up Studies; Humans; Imipramine; Male | 1992 |
Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program.
Topics: Adult; Ambulatory Care; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder | 1992 |
Differential relapse following cognitive therapy and pharmacotherapy for depression.
Topics: Adolescent; Adult; Ambulatory Care; Cognitive Behavioral Therapy; Combined Modality Therapy; Depress | 1992 |
Imipramine and weight gain during the long-term treatment of recurrent depression.
Topics: Adult; Body Mass Index; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Imipr | 1992 |
Maintenance treatment and psychobiologic correlates of endogenous subtypes.
Topics: Adult; Combined Modality Therapy; Depressive Disorder; Electroencephalography; Female; Follow-Up Stu | 1992 |
Novel selective serotonin reuptake inhibitors, Part II.
Topics: Adult; Aged; Ambulatory Care; Depressive Disorder; Humans; Imipramine; Neurotransmitter Uptake Inhib | 1992 |
Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.
Topics: Adult; Agoraphobia; Blood Pressure; Body Weight; Double-Blind Method; Drug Administration Schedule; | 1992 |
Protective effects of imipramine maintenance treatment in panic disorder with agoraphobia.
Topics: Adult; Agoraphobia; Ambulatory Care; Double-Blind Method; Drug Administration Schedule; Female; Foll | 1992 |
Stress, depression, and mania: relationship between perceived role of stressful events and clinical and biochemical characteristics.
Topics: Adaptation, Psychological; Adult; Amitriptyline; Arousal; Bipolar Disorder; Catecholamines; Depressi | 1990 |
Treatment of imipramine-resistant recurrent depression, IV: A double-blind crossover study of tranylcypromine for anergic bipolar depression.
Topics: Adolescent; Adult; Ambulatory Care; Bipolar Disorder; Double-Blind Method; Female; Humans; Imipramin | 1992 |
Treatment of imipramine-resistant recurrent depression, III: Efficacy of monoamine oxidase inhibitors.
Topics: Adult; Animals; Clinical Protocols; Combined Modality Therapy; Depressive Disorder; Female; Humans; | 1992 |
Efficacy of interpersonal psychotherapy as a maintenance treatment of recurrent depression. Contributing factors.
Topics: Adult; Combined Modality Therapy; Depressive Disorder; Female; Humans; Imipramine; Male; Placebos; P | 1991 |
Methodologic issues in maintenance therapy clinical trials.
Topics: Adult; Bipolar Disorder; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule | 1991 |
EEG sleep profiles and recurrent depression.
Topics: Adult; Aged; Combined Modality Therapy; Delta Rhythm; Depressive Disorder; Electroencephalography; F | 1991 |
Imipramine and weight gain during the treatment of recurrent depression.
Topics: Adult; Body Mass Index; Combined Modality Therapy; Depressive Disorder; Dose-Response Relationship, | 1990 |
Maintenance treatment and 6-month outcome for bulimic patients who respond to initial treatment.
Topics: Adolescent; Adult; Bulimia; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Imipramine | 1990 |
Three-year outcomes for maintenance therapies in recurrent depression.
Topics: Adult; Ambulatory Care; Clinical Protocols; Combined Modality Therapy; Depressive Disorder; Double-B | 1990 |
Delta sleep ratio. A biological correlate of early recurrence in unipolar affective disorder.
Topics: Adult; Age Factors; Aged; Biomarkers; Clinical Protocols; Cluster Analysis; Combined Modality Therap | 1990 |
Response to maintenance therapy in bipolar illness. Effect of index episode.
Topics: Actuarial Analysis; Bipolar Disorder; Chlorides; Depressive Disorder; Drug Therapy, Combination; Fem | 1989 |
Early recurrence in unipolar depression.
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Female; Follow-Up Studies; Humans; Imipramine; | 1989 |
Treatment of imipramine-resistant recurrent depression: I. An open clinical trial of adjunctive L-triiodothyronine.
Topics: Adult; Ambulatory Care; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; | 1989 |
Continuation drug therapy for major depressive episodes: how long should it be maintained?
Topics: Adult; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Dr | 1986 |
Research overview of drug therapy in recurrent and chronic depression.
Topics: Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method | 1985 |
Maintenance treatment of recurrent unipolar depression: pharmacology and psychotherapy.
Topics: Adult; Clinical Trials as Topic; Combined Modality Therapy; Depressive Disorder; Female; Humans; Imi | 1985 |
Continuation therapy with tricyclic antidepressants in depressive illness.
Topics: Amitriptyline; Clinical Trials as Topic; Depression; Humans; Imipramine; Placebos; Recurrence | 1972 |
An evaluation of continuation therapy with tricyclic antidepressants in depressive illness.
Topics: Adult; Aged; Amitriptyline; Clinical Trials as Topic; Depression; Evaluation Studies as Topic; Femal | 1973 |
Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness.
Topics: Adult; Affective Symptoms; Age Factors; Clinical Trials as Topic; Depression; Female; Hospitalizatio | 1973 |
Lithium prophylaxis in recurrent affective illness.
Topics: Acute Disease; Adult; Bipolar Disorder; Clinical Trials as Topic; Depression; Drug Evaluation; Femal | 1974 |
59 other studies available for imipramine and Recrudescence
| Article | Year |
|---|---|
Tobacco Consumption Concerns With the Use of CYP1A2 Metabolized Antidepressants.
Topics: Antidepressive Agents, Tricyclic; Cytochrome P-450 CYP1A2; Depressive Disorder, Major; Female; Genot | 2015 |
Adult hippocampal neuroplasticity triggers susceptibility to recurrent depression.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depressive Disorder; Disease Models, Animal; Disea | 2017 |
Long-term follow-up of enuretic alarm treatment in enuresis nocturna.
Topics: Adolescent; Behavior Therapy; Child; Child, Preschool; Combined Modality Therapy; Deamino Arginine V | 2008 |
A latent class approach to the external validation of respiratory and non-respiratory panic subtypes.
Topics: Age of Onset; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Diagnostic and Statistical Man | 2012 |
[There's not only Alzheimer's disease].
Topics: Accidental Falls; Aged; Alzheimer Disease; Antidepressive Agents; Cognition Disorders; Comorbidity; | 2012 |
Enlargement of brain cerebrospinal fluid spaces as a predictor of poor clinical outcome in melancholia.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Biomarkers; Cerebral Ventricles; Combined Modality Th | 2003 |
[DISAPPEARANCE OF RECURRENCES IN A PERIODIC SUBJECT (INTERMITTENT MELANCHOLIA) UNDER THE EFFECT OF A CONTINUOUS IMIPRAMINE TREATMENT].
Topics: Dementia; Depressive Disorder; Geriatrics; Humans; Imipramine; Mental Disorders; Periodicity; Psycho | 1963 |
Life stress and the long-term treatment course of recurrent depression: III. Nonsevere life events predict recurrence for medicated patients over 3 years.
Topics: Adult; Antidepressive Agents, Tricyclic; Combined Modality Therapy; Depressive Disorder, Major; Fema | 2006 |
Recurrence of dilated cardiomyopathy after re-introduction of a tricyclic antidepressant.
Topics: Antidepressive Agents, Tricyclic; Cardiomyopathy, Dilated; Female; Humans; Imipramine; Middle Aged; | 2006 |
Treatment of postpsychotic depression with sertraline in patients with schizophrenia--own experience.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depression; Female; Humans; Imiprami | 2006 |
Imipramine in persistent vomiting.
Topics: Adult; Antidepressive Agents, Tricyclic; Antiemetics; Chronic Disease; Eating; Female; Humans; Imipr | 2006 |
Bupropion's prophylactic efficacy in bipolar affective illness.
Topics: Acute Disease; Adult; Antidepressive Agents; Bipolar Disorder; Bupropion; Drug Administration Schedu | 1983 |
Biological and clinical predictors of response in recurrent depression: a preliminary report.
Topics: Adult; Circadian Rhythm; Combined Modality Therapy; Depressive Disorder; Drug Therapy, Combination; | 1984 |
Social skills training and endogenous depression.
Topics: Adult; Amitriptyline; Behavior Therapy; Depressive Disorder; Female; Follow-Up Studies; Humans; Imip | 1984 |
Pituitary-adrenal disinhibition in depression: marker of a subtype with characteristic clinical features and response to treatment?
Topics: Adult; Amitriptyline; Clomipramine; Depressive Disorder; Desipramine; Dexamethasone; Female; Humans; | 1981 |
Lithium treatment and prophylaxis in unipolar depression.
Topics: Acute Disease; Depression; Humans; Imipramine; Lithium; Maprotiline; Recurrence | 1980 |
[Long-term antidepressant drug treatment in Champagne].
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Combined Modality Therapy; Depressive Disor | 1995 |
Cost-effectiveness of antidepressants.
Topics: Ambulatory Care; Cost-Benefit Analysis; Depressive Disorder; Humans; Imipramine; Paroxetine; Patient | 1994 |
Imipramine and sexual dysfunction during the long-term treatment of recurrent depression.
Topics: Adult; Depressive Disorder; Female; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating | 1994 |
The role of Melipramine in the treatment of bladder instability.
Topics: Drug Evaluation; Female; Humans; Imipramine; Male; Recurrence; Treatment Outcome; Urinary Incontinen | 1993 |
Maintenance therapy in depression.
Topics: Combined Modality Therapy; Depressive Disorder; Humans; Imipramine; Proportional Hazards Models; Psy | 1994 |
Prediction and decision making using Bayesian hierarchical models.
Topics: Antidepressive Agents, Tricyclic; Bayes Theorem; Cost-Benefit Analysis; Decision Making; Depressive | 1995 |
Life stress and treatment course of recurrent depression: II. Postrecovery associations with attrition, symptom course, and recurrence over 3 years.
Topics: Adult; Antidepressive Agents, Tricyclic; Combined Modality Therapy; Depressive Disorder; Female; Fol | 1996 |
Recovery from major depression. A 10-year prospective follow-up across multiple episodes.
Topics: Adult; Combined Modality Therapy; Depressive Disorder; Female; Follow-Up Studies; Humans; Imipramine | 1997 |
Recovery from major depression. A 10-year prospective follow-up across multiple episodes.
Topics: Adult; Combined Modality Therapy; Depressive Disorder; Female; Follow-Up Studies; Humans; Imipramine | 1997 |
Recovery from major depression. A 10-year prospective follow-up across multiple episodes.
Topics: Adult; Combined Modality Therapy; Depressive Disorder; Female; Follow-Up Studies; Humans; Imipramine | 1997 |
Recovery from major depression. A 10-year prospective follow-up across multiple episodes.
Topics: Adult; Combined Modality Therapy; Depressive Disorder; Female; Follow-Up Studies; Humans; Imipramine | 1997 |
Temporal profiles of the course of depression during treatment. Predictors of pathways toward recovery in the elderly.
Topics: Age Factors; Age of Onset; Aged; Cluster Analysis; Combined Modality Therapy; Depressive Disorder; E | 1997 |
Cost analysis of paroxetine versus imipramine in major depression.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Computer Simulation; Cos | 1995 |
A comparison of two life stress assessment approaches: prospective prediction of treatment outcome in recurrent depression.
Topics: Adult; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Imipramine; Life Chang | 2000 |
Combined pharmacotherapy for nocturnal enuresis.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Benzilates; Child; Cholinergic Antagonists; Drug Th | 2001 |
Treatment of unipolar depression following electroconvulsive therapy. Relapse rate comparisons between lithium and tricyclics therapies following ECT.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Electroconvulsive Therapy; Female; Hum | 1979 |
[Recurrent ventricular fibrillation in a patient treated with imipramine].
Topics: Depression; Female; Humans; Imipramine; Middle Aged; Recurrence; Ventricular Fibrillation | 1977 |
Psychological medicine. Management of depression.
Topics: Amitriptyline; Antidepressive Agents; Anxiety; Clomipramine; Depression; Drug Interactions; Electroc | 1975 |
MDMA ("ecstasy") and panic disorder: induction by a single dose.
Topics: 3,4-Methylenedioxyamphetamine; Administration, Oral; Adult; Alprazolam; Anxiety Disorders; Arousal; | 1992 |
Maintenance treatment in recurrent depression: current and future directions. The first William Sargant Lecture.
Topics: Adolescent; Adult; Aged; Biomarkers; Chronic Disease; Depressive Disorder; Electroencephalography; F | 1992 |
Life stress and treatment course of recurrent depression: 1. Response during index episode.
Topics: Adjustment Disorders; Adult; Combined Modality Therapy; Depressive Disorder; Female; Humans; Imipram | 1992 |
Exploratory statistical methods, with applications to psychiatric research.
Topics: Clinical Trials as Topic; Data Interpretation, Statistical; Depressive Disorder; Dexamethasone; Huma | 1992 |
Lithium augmentation in geriatric depression.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Bipolar Disorder; Delayed-Action Preparat | 1990 |
Recurrent depression is associated with a persistent reduction in sleep-related growth hormone secretion.
Topics: Adult; Aged; Ambulatory Care; Biomarkers; Depressive Disorder; Desipramine; Electroencephalography; | 1990 |
Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms.
Topics: Adult; Desipramine; Diabetic Neuropathies; Dose-Response Relationship, Drug; Female; Humans; Imipram | 1990 |
Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study.
Topics: Adult; Agoraphobia; Akathisia, Drug-Induced; Antidepressive Agents, Tricyclic; Anxiety Disorders; Ap | 1989 |
The advantage of early treatment intervention in recurrent depression.
Topics: Adult; Combined Modality Therapy; Depressive Disorder; Female; Humans; Imipramine; Male; Outcome and | 1989 |
Childhood depression: five-year outcome following combined cognitive-behavior therapy and pharmacotherapy.
Topics: Behavior Therapy; Child; Cognition; Combined Modality Therapy; Depressive Disorder; Female; Follow-U | 1988 |
Continuation and maintenance treatment trials of adjunctive imipramine therapy in patients with postpsychotic depression.
Topics: Benztropine; Depressive Disorder; Drug Therapy, Combination; Fluphenazine; Humans; Imipramine; Psych | 1988 |
Suicide upon recovery from depression. A clinical note.
Topics: Adult; Bipolar Disorder; Depressive Disorder; Desipramine; Electroconvulsive Therapy; Female; Humans | 1988 |
Personality pathology in recurrent depression: nature, prevalence, and relationship to treatment response.
Topics: Adult; Aged; Depressive Disorder; Female; Humans; Imipramine; Male; Middle Aged; Outcome and Process | 1988 |
Possible role of antidepressants in precipitating mania and hypomania in recurrent depression.
Topics: Adult; Age Factors; Bipolar Disorder; Depressive Disorder; Female; Humans; Imipramine; Male; Middle | 1988 |
Schizophrenia research heads NIMH priorities.
Topics: Combined Modality Therapy; Depressive Disorder; Humans; Imipramine; National Institute of Mental Hea | 1987 |
Verapamil in the treatment of recurrent unipolar depression.
Topics: Adult; Calcium; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Imipramine; Lithium; | 1987 |
Efficacy of combined imipramine and interpersonal psychotherapy.
Topics: Adult; Combined Modality Therapy; Depressive Disorder; Humans; Imipramine; Psychotherapy; Recurrence | 1987 |
Bipolar disorder: are there manic-prone and depressive-prone forms?
Topics: Bipolar Disorder; Depressive Disorder; Humans; Imipramine; Lithium; Recurrence | 1986 |
Psychotherapeutic approaches to treatment of recurrent unipolar depression: work in progress.
Topics: Adult; Combined Modality Therapy; Depressive Disorder; Female; Humans; Imipramine; Male; Middle Aged | 1986 |
Relapse in recurrent unipolar depression.
Topics: Acute Disease; Adult; Combined Modality Therapy; Depressive Disorder; Female; Humans; Imipramine; Ma | 1987 |
Tolerance to therapeutic effects of antidepressants.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Chronic Disease; Depressive Disorder; Desipramine | 1985 |
Antidepressant treatment of children: clinical relapse is unrelated to tricyclic plasma concentrations.
Topics: Adolescent; Amitriptyline; Biotransformation; Child; Depressive Disorder; Drug Tolerance; Humans; Im | 1985 |
Therapy resistant depressions. Methodological problems. Contributions to methodical questions and animal-experimental aspects.
Topics: Antidepressive Agents; Depression; Drug Resistance; Hospitalization; Humans; Imipramine; Lithium; Me | 1974 |
Conditioning techniques and enuresis.
Topics: Acoustic Stimulation; Amphetamine; Attitude of Health Personnel; Behavior Therapy; Child; Child Beha | 1973 |
Is response to antidepressants an aid to the differentiation of response-specific types of depression?
Topics: Adult; Amitriptyline; Depression; Humans; Imipramine; Male; Middle Aged; Nialamide; Recurrence | 1973 |
Continuation therapy with tricyclic drugs in depressive illness.
Topics: Amitriptyline; Antidepressive Agents; Humans; Imipramine; Recurrence | 1973 |
Age-sex differences in response to antidepressant drugs.
Topics: Adjustment Disorders; Adolescent; Adult; Age Factors; Aged; Antidepressive Agents; Anxiety; Chlorpro | 1974 |
Phobic anxiety syndrome complicated by drug dependence and addiction. A treatable form of drug abuse.
Topics: Adult; Anxiety; Electroconvulsive Therapy; Ethanol; Evaluation Studies as Topic; Female; Hospitaliza | 1972 |